RNU6ATAC36P

Across TCGA pan-cancer cohorts, RNU6ATAC36P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RNU6ATAC36P’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RNU6ATAC36P RNA is repressed in tumor relative to normal tissue. In most cancer types RNU6ATAC36P is over-expressed in tumor, although a few such as COAD and THCA show the opposite, repressed pattern.

COAD, THCA, and KIRC are the cancer types where RNU6ATAC36P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6ATAC36P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	−0.090	.042	2	view →
THCA	All	II,III,IV	−0.459	.036	1	view →
KIRC	All	All	−0.089	.026	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RNU6ATAC36P–COAD

Open the COAD breakdown →